Teva Drug Patent Portfolio
Teva owns 36 orange book drugs protected by 179 US patents with Alvaiz having the least patent protection, holding only 1 patent. And Airduo Digihaler with maximum patent protection, holding 60 patents. Given below is the list of Teva's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12329851 | 17 Mar, 2042 | Active | |
| US11266796 | Inhalation device with integrated electronics | 22 Aug, 2041 | Active |
| US11311488 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | 10 Jun, 2041 | Active |
| US11266796 | Inhalation device with integrated electronics | 22 Feb, 2041 | Active |
| US11173259 | Drug delivery device with electronics and power management | 06 Jan, 2041 | Active |
| US11464923 | Inhaler system | 19 Dec, 2040 | Active |
| US11439777 | Drug delivery device with electronics | 24 Nov, 2040 | Active |
| US12128132 | Drug delivery formulations | 11 Sep, 2040 | Active |
| US12383493 | 11 Sep, 2040 | Active | |
| US11173259 | Drug delivery device with electronics and power management | 06 Jul, 2040 | Active |
| US11464923 | Inhaler system | 19 Jun, 2040 | Active |
| US11439777 | Drug delivery device with electronics | 24 May, 2040 | Active |
| US11344685 | Drug delivery device with electronics | 26 Mar, 2040 | Active |
| US11969544 | Inhalers and airflow adaptors therefor | 20 Feb, 2040 | Active |
| US11344685 | Drug delivery device with electronics | 26 Sep, 2039 | Active |
| US11969544 | Inhalers and airflow adaptors therefor | 20 Aug, 2039 | Active |
| US11000653 | Inhaler | 18 Jun, 2039 | Active |
| US11357935 | Drug delivery device with electronics | 24 Mar, 2039 | Active |
| US11000653 | Inhaler | 18 Dec, 2038 | Active |
| US11072586 | Solid state forms of eltrombopag choline | 05 Nov, 2038 | Active |
| US11357935 | Drug delivery device with electronics | 24 Sep, 2038 | Active |
| US11179386 | Analogs of deutetrabenazine, their preparation and use | 15 Sep, 2038 | Active |
| US11813232 | Analogs of deutetrabenazine, their preparation and use | 15 Sep, 2038 | Active |
| US11351317 | Drug delivery device with electronics | 10 Aug, 2038 | Active |
| US11179386 | Analogs of deutetrabenazine, their preparation and use | 15 Mar, 2038 | Active |
| US11813232 | Analogs of deutetrabenazine, their preparation and use | 15 Mar, 2038 | Active |
| US11351317 | Drug delivery device with electronics | 10 Feb, 2038 | Active |
| US10569034 | Compliance monitoring module for a breath-actuated inhaler | 16 Feb, 2037 | Active |
| US10959996 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US11357772 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US11446291 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US11564917 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US11648244 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US12016858 | Methods for the treatment of abnormal involuntary movement disorders | 07 Sep, 2036 | Active |
| US10569034 | Compliance monitoring module for a breath-actuated inhaler | 16 Aug, 2036 | Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler | 14 Jun, 2036 | Active |
| US10959996 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US11357772 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US11446291 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US11564917 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US11648244 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US12016858 | Methods for the treatment of abnormal involuntary movement disorders | 07 Mar, 2036 | Active |
| US9782550 | Compliance monitoring module for a breath-actuated inhaler | 28 Feb, 2036 | Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler | 28 Feb, 2036 | Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler | 14 Dec, 2035 | Active |
| US9782550 | Compliance monitoring module for a breath-actuated inhaler | 28 Aug, 2035 | Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler | 28 Aug, 2035 | Active |
| US9066957 | Dry powder inhaler | 06 Apr, 2035 | Active |
| US9415008 | Dry powder inhaler | 06 Apr, 2035 | Active |
| US9066957 | Dry powder inhaler | 06 Oct, 2034 | Active |
| US9415008 | Dry powder inhaler | 06 Oct, 2034 | Active |
| US11666566 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Mar, 2034 | Active |
| US9233959 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Mar, 2034 | Active |
| US9296739 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Mar, 2034 | Active |
| US9550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Mar, 2034 | Active |
| US9814708 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Mar, 2034 | Active |
| US11666566 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Sep, 2033 | Active |
| US9233959 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Sep, 2033 | Active |
| US9296739 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Sep, 2033 | Active |
| US9550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Sep, 2033 | Active |
| US9814708 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | 18 Sep, 2033 | Active |
| US9023897 | Biodegradable drug delivery compositions | 05 Apr, 2033 | Active |
| US9327114 | User-activated self-contained co-packaged iontophoretic drug delivery system | 08 Oct, 2032 | Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler | 25 Aug, 2032 | Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | 13 Jul, 2032 | Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | 01 Jul, 2032 | Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler | 25 Feb, 2032 | Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | 13 Jan, 2032 | Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | 01 Jan, 2032 | Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | 28 Dec, 2031 | Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | 18 Nov, 2031 | Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 Nov, 2031 | Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement | 18 Nov, 2031 | Active |
| US10188811 | Nasal spray device | 21 Oct, 2031 | Active |
| US8524733 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | 03 Oct, 2031 | Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler | 14 Aug, 2031 | Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | 28 Jun, 2031 | Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | 18 May, 2031 | Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement | 18 May, 2031 | Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement | 18 May, 2031 | Active |
| US10086156 | Dose counter for inhaler and method for counting doses | 18 May, 2031 | Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof | 18 May, 2031 | Active |
| US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator | 18 May, 2031 | Active |
| US8524733 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | 03 Apr, 2031 | Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler | 14 Feb, 2031 | Active |
| US8983594 | Electronic control of drug delivery system | 19 Nov, 2030 | Active |
| US8232250 | Low frequency glatiramer acetate therapy | 19 Aug, 2030 | Active |
| US8399413 | Low frequency glatiramer acetate therapy | 19 Aug, 2030 | Active |
| US8969302 | Low frequency glatiramer acetate therapy | 19 Aug, 2030 | Active |
| US9155776 | Low frequency glatiramer acetate therapy | 19 Aug, 2030 | Active |
| US9402874 | Low frequency glatiramer acetate therapy | 19 Aug, 2030 | Active |
| US8445018 | Abuse resistant drug formulation | 31 Jul, 2029 | Active |
| US8366600 | Polyamine enhanced formulations for triptan compound iontophoresis | 21 Apr, 2029 | Active |
| US8415332 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | 11 Mar, 2029 | Active |
| US7855190 | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration | 05 Dec, 2028 | Active |
| US8651103 | Dry powder inhalation apparatus | 26 Sep, 2028 | Active |
| US8132712 | Metered-dose inhaler | 07 Sep, 2028 | Active |
| US8651103 | Dry powder inhalation apparatus | 26 Mar, 2028 | Active |
| US8221778 | Drug-containing implants and methods of use thereof | 12 Nov, 2027 | Active |
| US8741327 | Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant | 12 Nov, 2027 | Active |
| US9216176 | Abuse resistant drug formulation | 13 Sep, 2027 | Active |
| US9572803 | Abuse resistant drug formulation | 13 Sep, 2027 | Active |
| US9272137 | Transdermal methods and systems for the delivery of anti-migraine compounds | 07 Sep, 2027 | Active |
| US7815942 | Rasagiline formulations of improved content uniformity | 27 Aug, 2027 | Active |
| US7973058 | Transdermal methods and systems for the delivery of anti-migraine compounds | 12 Apr, 2027 | Active |
| US8155737 | Pharmacokinetics of iontophoretic sumatriptan administration | 12 Apr, 2027 | Active |
| US8470853 | Transdermal methods and systems for the delivery of anti-migraine compounds | 12 Apr, 2027 | Active |
| US8597272 | Pharmacokinetics of iontophoretic sumatriptan administration | 12 Apr, 2027 | Active |
| US9427578 | Pharmacokinetics of iontophoretic sumatriptan administration | 12 Apr, 2027 | Active |
| US7780038 | Dispensing apparatus with dosage counter | 24 Jan, 2027 | Active |
| US7572834 | Rasagiline formulations and processes for their preparation | 05 Dec, 2026 | Active |
| US6987103 | Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents | 26 Oct, 2026 | Active |
| US10765820 | Dry powder inhalation apparatus | 19 Nov, 2025 | Expired |
| US9463288 | Dry powder inhalation apparatus | 19 Nov, 2025 | Expired |
| US8450299 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens | 07 Oct, 2025 | Expired |
| US10765820 | Dry powder inhalation apparatus | 19 May, 2025 | Expired |
| US9463288 | Dry powder inhalation apparatus | 19 May, 2025 | Expired |
| US9616024 | Process for preparing a medicament | 01 Mar, 2025 | Expired |
| US9987229 | Process for preparing a medicament | 01 Mar, 2025 | Expired |
| US7387793 | Modified release dosage forms of skeletal muscle relaxants | 26 Feb, 2025 | Expired |
| US10736965 | Risperidone biodegradable implant | 12 Jan, 2025 | Expired |
| US8802127 | Risperidone-containing PLA:PGA implants and methods of use thereof | 12 Jan, 2025 | Expired |
| US9439905 | Risperidone-containing implants and methods of use thereof | 12 Jan, 2025 | Expired |
| US9717799 | Drug-containing implants and methods of use thereof | 12 Jan, 2025 | Expired |
| US9895447 | Drug-containing PLA implants and methods of use thereof | 12 Jan, 2025 | Expired |
| US9925268 | Drug-containing implants and methods of use thereof | 12 Jan, 2025 | Expired |
| US7456207 | Vaginal pharmaceutical compositions and methods for preparing them | 22 Sep, 2024 | Expired |
| US9616024 | Process for preparing a medicament | 01 Sep, 2024 | Expired |
| US9987229 | Process for preparing a medicament | 01 Sep, 2024 | Expired |
| US7320969 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | 30 Jan, 2024 | Expired |
| US7544372 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US7790199 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US7820203 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US7829121 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US8877245 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US9375410 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US9399025 | Modified release dosage forms of skeletal muscle relaxants | 14 Nov, 2023 | Expired |
| US7540282 | Reservoir pressure system for medicament inhaler | 06 Nov, 2023 | Expired |
| US7105152 | Suspension aerosol formulations | 12 Sep, 2023 | Expired |
| US7858605 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | 23 Jun, 2023 | Expired |
| US7615545 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | 15 Jun, 2023 | Expired |
| US7540282 | Reservoir pressure system for medicament inhaler | 06 May, 2023 | Expired |
| US6745071 | Iontophoretic drug delivery system | 21 Feb, 2023 | Expired |
| US6701917 | Dose counter for medicament inhaler | 23 Jun, 2021 | Expired |
| US6718972 | Dose metering system for medicament inhaler | 23 Jun, 2021 | Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler | 23 Jun, 2021 | Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler | 23 Jun, 2021 | Expired |
| US8006690 | Reservoir pressure system for medicament inhaler | 23 Jun, 2021 | Expired |
| US6384020 | Rapid immediate release oral dosage form | 06 Jan, 2021 | Expired |
| US6156742 | Emergency contraceptive kit | 05 Dec, 2020 | Expired |
| US6384020 | Rapid immediate release oral dosage form | 06 Jul, 2020 | Expired |
| US7320970 | Low dose estrogen interrupted hormone replacement therapy | 30 Mar, 2020 | Expired |
| US6747019 | Low dose estrogen interrupted hormone replacement therapy | 20 Mar, 2020 | Expired |
| US6667050 | Chewable oral contraceptive | 06 Apr, 2019 | Expired |
| US7842687 | Cephalotaxane derivatives and their processes of preparation and purification | 16 Mar, 2019 | Expired |
| USRE45128 | Cephalotaxane derivatives and their processes of preparation and purification | 16 Mar, 2019 | Expired |
| US6446627 | Inhaler dose counter | 18 Dec, 2017 | Expired |
| US5898032 | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy | 23 Jun, 2017 | Expired |
| USRE39861 | Methods of extended use oral contraception | 23 Jun, 2017 | Expired |
| US7566445 | Medicinal aerosols and methods of delivery thereof | 04 Jun, 2017 | Expired |
| US8834849 | Medicinal aerosols and methods of delivery thereof | 04 Jun, 2017 | Expired |
| US5453446 | Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease. | 07 Feb, 2017 | Expired |
| US6126968 | Stable compositions containing N-propargyl-1-aminoindan | 18 Sep, 2016 | Expired |
| US5776432 | Beclomethasone solution aerosol formulations | 07 Jul, 2015 | Expired |
| US5683677 | Medicinal aerosol formulations | 04 Nov, 2014 | Expired |
| US5552394 | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy | 22 Jul, 2014 | Expired |
| US5981589 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US6054430 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US6342476 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US6362161 | Copolymer-1 improvements on compositions of copolymers | 24 May, 2014 | Expired |
| US6620847 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US6939539 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US7199098 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US8367605 | Copolymer-1 improvements in compositions of copolymers | 24 May, 2014 | Expired |
| US5605674 | Medicinal aerosol formulations | 25 Feb, 2014 | Expired |
| US5532415 | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof | 02 Jul, 2013 | Expired |
Latest Legal Activities on Teva's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Teva.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Jun, 2024 | US9550780 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Jun, 2024 | US9550780 |
|
Expire Patent
Critical
| 10 Jun, 2024 | US9327114 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Apr, 2024 | US10736965 |
| Surcharge for Late Payment, Large Entity | 17 Apr, 2024 | US10736965 |
|
Maintenance Fee Reminder Mailed
Critical
| 01 Apr, 2024 | US10736965 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463289 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Mar, 2024 | US9463288 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Feb, 2024 | US9439905 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 21 Feb, 2024 | US10765820 |
Teva's Drug Patent Litigations
Teva's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Feb 16, 2016, against patent number US9155776. The petitioner Mylan Pharmaceuticals Inc. et al., challenged the validity of this patent, with Yeda Research and Development Co. Ltd. et al. as the respondent. Click below to track the latest information on how companies are challenging Teva's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8524733 | September, 2021 |
Institution Denied
(09 Mar, 2022)
| Auspex Pharmaceuticals, Inc. et al. | Apotex Inc. et al. |
| US8524733 | September, 2021 |
Terminated-Denied
(09 Mar, 2022)
| Auspex Pharmaceuticals, Inc. | Apotex Inc. |
| US10561808 | October, 2018 |
Decision
(20 Sep, 2019)
| Declan Walsh et al. | |
| US9155776 | November, 2016 |
Terminated
(02 May, 2017)
| Yeda Research & Development Co., Ltd. et al. | Mylan Pharmaceuticals Inc. et al. |
| US9155776 | July, 2016 |
Terminated
(13 Oct, 2016)
| YEDA RESEARCH & DEVELOPMENT CO., LTD. | Amneal Pharmaceuticals LLC et al. |
| US8969302 | September, 2015 |
FWD Entered
(01 Sep, 2016)
| YEDA RESEARCH & DEVELOPMENT CO. LTD. | Amneal Pharmaceuticals LLC |
| US8969302 | March, 2015 |
FWD Entered
(01 Sep, 2016)
| Yeda Research & Development Co., Ltd. | Mylan Pharmaceuticals Inc. |
| US8969302 | September, 2015 |
Final Written Decision
(01 Sep, 2016)
| YEDA RESEARCH & DEVELOPMENT CO. LTD. et al. | Amneal Pharmaceuticals LLC |
| US8969302 | March, 2015 |
Final Written Decision
(01 Sep, 2016)
| Yeda Research & Development Co., Ltd. et al. | Mylan Pharmaceuticals Inc. et al. |
| US8399413 | September, 2015 |
FWD Entered
(24 Aug, 2016)
| YEDA RESEARCH & DEVELOPMENT CO. LTD. | Amneal Pharmaceuticals LLC |
| US8399413 | February, 2015 |
FWD Entered
(24 Aug, 2016)
| Yeda Research and Development Co. Ltd. | Mylan Pharmaceuticals Inc. |
| US8232250 | September, 2015 |
Final Written Decision
(24 Aug, 2016)
| Yeda Research & Development Co., Ltd. et al. | Amneal Pharmaceuticals LLC |
| US8232250 | February, 2015 |
FWD Entered
(24 Aug, 2016)
| Yeda Research and Development Co. Ltd. | Mylan Pharmaceuticals Inc. |
| US8399413 | February, 2015 |
Final Written Decision
(24 Aug, 2016)
| Yeda Research and Development Co. Ltd. et al. | Mylan Pharmaceuticals Inc. et al. |
| US8399413 | September, 2015 |
Final Written Decision
(24 Aug, 2016)
| YEDA RESEARCH & DEVELOPMENT CO. LTD. et al. | Amneal Pharmaceuticals LLC |
| US8232250 | February, 2015 |
Final Written Decision
(24 Aug, 2016)
| Yeda Research and Development Co. Ltd. et al. | Mylan Pharmaceuticals Inc. et al. |
| US9155776 | February, 2016 |
Terminated-Denied
(15 Aug, 2016)
| Yeda Research and Development Co. Ltd. | Mylan Pharmaceuticals Inc. |
| US9155776 | February, 2016 |
Institution Denied
(15 Aug, 2016)
| Yeda Research and Development Co. Ltd. et al. | Mylan Pharmaceuticals Inc. et al. |
Teva Drug Patents' Oppositions Filed in EPO
Teva drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 03, 2009, by Vectura Delivery Devices Limited. This opposition was filed on patent number EP01948660A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP20172454A | Nov, 2022 | Vectura Limited | Granted and Under Opposition |
| EP19155324A | Jun, 2021 | Vectura Limited | Granted and Under Opposition |
| EP17811276A | Mar, 2021 | VECTURA DELIVERY DEVICES LIMITED | Opposition rejected |
| EP17800844A | Jun, 2020 | Vectura Limited | Opposition rejected |
| EP17800844A | Feb, 2020 | CHIESI FARMACEUTICI S.p.A. | Opposition rejected |
| EP06720975A | Feb, 2017 | Generics (U.K.) Limited | Patent maintained as amended |
| EP11779089A | Jan, 2016 | FRKelly | Opposition rejected |
| EP04782768A | Apr, 2015 | AstraZeneca Pharma Poland Sp. z.o.o. | Revoked |
| EP01948660A | Aug, 2014 | Hexal Aktiengesellschaft | Patent maintained as amended |
| EP02782404A | Jun, 2014 | Laboratorios Léon Farma, S.A. | Revoked |
| EP02782404A | Jun, 2014 | Bröcher, Dirk Joachim | Revoked |
| EP04782768A | Nov, 2011 | Vectura Limited | Revoked |
| EP04782768A | Nov, 2011 | AstraZeneca AB | Revoked |
| EP01948660A | Sep, 2009 | Vectura Delivery Devices Limited | Patent maintained as amended |
Teva's Family Patents
Teva drugs have patent protection in a total of 46 countries. It's US patent count contributes only to 23.5% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Recent FDA approvals and tentative approvals for Teva
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Sheur |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 22 Sep, 2025 |
| Nintedanib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 15 Aug, 2025 |
| Azacitidine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 10 Apr, 2025 |
Teva Drug List
Given below is the complete list of Teva's drugs and the patents protecting them.
1. Adderall 10
Adderall 10 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 10's drug page
2. Adderall 12.5
Adderall 12.5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 12.5's drug page
3. Adderall 15
Adderall 15 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 15's drug page
4. Adderall 20
Adderall 20 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 20's drug page
5. Adderall 30
Adderall 30 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 30's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
6. Adderall 5
Adderall 5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 5's drug page
7. Adderall 7.5
Adderall 7.5 is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6384020
(Pediatric)
| Rapid immediate release oral dosage form |
06 Jan, 2021
(5 years ago)
| Expired |
| US6384020 | Rapid immediate release oral dosage form |
06 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adderall 7.5's drug page
8. Airduo Digihaler
Airduo Digihaler is protected by 60 patents, out of which 15 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11266796
(Pediatric)
| Inhalation device with integrated electronics |
22 Aug, 2041
(15 years from now)
| Active |
| US11266796 | Inhalation device with integrated electronics |
22 Feb, 2041
(15 years from now)
| Active |
| US11173259
(Pediatric)
| Drug delivery device with electronics and power management |
06 Jan, 2041
(14 years from now)
| Active |
| US11173259 | Drug delivery device with electronics and power management |
06 Jul, 2040
(14 years from now)
| Active |
| US11464923 | Inhaler system |
19 Jun, 2040
(14 years from now)
| Active |
| US11439777 | Drug delivery device with electronics |
24 May, 2040
(14 years from now)
| Active |
| US11344685
(Pediatric)
| Drug delivery device with electronics |
26 Mar, 2040
(14 years from now)
| Active |
| US11969544
(Pediatric)
| Inhalers and airflow adaptors therefor |
20 Feb, 2040
(14 years from now)
| Active |
| US11344685 | Drug delivery device with electronics |
26 Sep, 2039
(13 years from now)
| Active |
| US11969544 | Inhalers and airflow adaptors therefor |
20 Aug, 2039
(13 years from now)
| Active |
| US11000653
(Pediatric)
| Inhaler |
18 Jun, 2039
(13 years from now)
| Active |
| US11000653 | Inhaler |
18 Dec, 2038
(12 years from now)
| Active |
| US11357935 | Drug delivery device with electronics |
24 Sep, 2038
(12 years from now)
| Active |
| US11351317
(Pediatric)
| Drug delivery device with electronics |
10 Aug, 2038
(12 years from now)
| Active |
| US11351317 | Drug delivery device with electronics |
10 Feb, 2038
(12 years from now)
| Active |
| US10569034
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
16 Feb, 2037
(11 years from now)
| Active |
| US10569034 | Compliance monitoring module for a breath-actuated inhaler |
16 Aug, 2036
(10 years from now)
| Active |
| US10918816
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
14 Jun, 2036
(10 years from now)
| Active |
| US9782550
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
28 Feb, 2036
(10 years from now)
| Active |
| US9782551
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
28 Feb, 2036
(10 years from now)
| Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler |
14 Dec, 2035
(9 years from now)
| Active |
| US9782550 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US9066957
(Pediatric)
| Dry powder inhaler |
06 Apr, 2035
(9 years from now)
| Active |
| US9415008
(Pediatric)
| Dry powder inhaler |
06 Apr, 2035
(9 years from now)
| Active |
| US9066957 | Dry powder inhaler |
06 Oct, 2034
(8 years from now)
| Active |
| US9415008 | Dry powder inhaler |
06 Oct, 2034
(8 years from now)
| Active |
| US8714149
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
25 Aug, 2032
(6 years from now)
| Active |
| US8978966
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jul, 2032
(6 years from now)
| Active |
| US10561808
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jul, 2032
(6 years from now)
| Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler |
25 Feb, 2032
(6 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Dec, 2031
(5 years from now)
| Active |
| US10022510
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
18 Nov, 2031
(5 years from now)
| Active |
| US10124131
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
18 Nov, 2031
(5 years from now)
| Active |
| US9731087
(Pediatric)
| Dose counter for inhaler having a bore and shaft arrangement |
18 Nov, 2031
(5 years from now)
| Active |
| US10195375
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
14 Aug, 2031
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler |
14 Feb, 2031
(5 years from now)
| Active |
| US8651103
(Pediatric)
| Dry powder inhalation apparatus |
26 Sep, 2028
(2 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US9463288
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9616024
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9987229
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9616024 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US9987229 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US7540282
(Pediatric)
| Reservoir pressure system for medicament inhaler |
06 Nov, 2023
(2 years ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Airduo Digihaler's drug page
9. Airduo Respiclick
Airduo Respiclick is protected by 40 patents, out of which 16 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11969544
(Pediatric)
| Inhalers and airflow adaptors therefor |
20 Feb, 2040
(14 years from now)
| Active |
| US11969544 | Inhalers and airflow adaptors therefor |
20 Aug, 2039
(13 years from now)
| Active |
| US9066957
(Pediatric)
| Dry powder inhaler |
06 Apr, 2035
(9 years from now)
| Active |
| US9415008
(Pediatric)
| Dry powder inhaler |
06 Apr, 2035
(9 years from now)
| Active |
| US9066957 | Dry powder inhaler |
06 Oct, 2034
(8 years from now)
| Active |
| US9415008 | Dry powder inhaler |
06 Oct, 2034
(8 years from now)
| Active |
| US8714149
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
25 Aug, 2032
(6 years from now)
| Active |
| US8978966
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jul, 2032
(6 years from now)
| Active |
| US10561808
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jul, 2032
(6 years from now)
| Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler |
25 Feb, 2032
(6 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Dec, 2031
(5 years from now)
| Active |
| US10022510
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
18 Nov, 2031
(5 years from now)
| Active |
| US10124131
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
18 Nov, 2031
(5 years from now)
| Active |
| US9731087
(Pediatric)
| Dose counter for inhaler having a bore and shaft arrangement |
18 Nov, 2031
(5 years from now)
| Active |
| US10195375
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
14 Aug, 2031
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler |
14 Feb, 2031
(5 years from now)
| Active |
| US8651103
(Pediatric)
| Dry powder inhalation apparatus |
26 Sep, 2028
(2 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US9463288
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9616024
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9987229
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9616024 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US9987229 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US7540282
(Pediatric)
| Reservoir pressure system for medicament inhaler |
06 Nov, 2023
(2 years ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Airduo Respiclick's drug page
10. Alvaiz
Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11072586 | Solid state forms of eltrombopag choline |
05 Nov, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page
11. Amrix
Amrix is protected by 8 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7387793 | Modified release dosage forms of skeletal muscle relaxants |
26 Feb, 2025
(10 months ago)
| Expired |
| US7544372 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US7790199 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US7820203 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US7829121 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US8877245 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US9375410 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
| US9399025 | Modified release dosage forms of skeletal muscle relaxants |
14 Nov, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Amrix's drug page
12. Armonair Digihaler
Armonair Digihaler is protected by 57 patents, out of which 13 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11266796
(Pediatric)
| Inhalation device with integrated electronics |
22 Aug, 2041
(15 years from now)
| Active |
| US11266796 | Inhalation device with integrated electronics |
22 Feb, 2041
(15 years from now)
| Active |
| US11173259
(Pediatric)
| Drug delivery device with electronics and power management |
06 Jan, 2041
(14 years from now)
| Active |
| US11464923
(Pediatric)
| Inhaler system |
19 Dec, 2040
(14 years from now)
| Active |
| US11439777
(Pediatric)
| Drug delivery device with electronics |
24 Nov, 2040
(14 years from now)
| Active |
| US11173259 | Drug delivery device with electronics and power management |
06 Jul, 2040
(14 years from now)
| Active |
| US11464923 | Inhaler system |
19 Jun, 2040
(14 years from now)
| Active |
| US11439777 | Drug delivery device with electronics |
24 May, 2040
(14 years from now)
| Active |
| US11344685
(Pediatric)
| Drug delivery device with electronics |
26 Mar, 2040
(14 years from now)
| Active |
| US11969544
(Pediatric)
| Inhalers and airflow adaptors therefor |
20 Feb, 2040
(14 years from now)
| Active |
| US11344685 | Drug delivery device with electronics |
26 Sep, 2039
(13 years from now)
| Active |
| US11969544 | Inhalers and airflow adaptors therefor |
20 Aug, 2039
(13 years from now)
| Active |
| US11000653
(Pediatric)
| Inhaler |
18 Jun, 2039
(13 years from now)
| Active |
| US11357935
(Pediatric)
| Drug delivery device with electronics |
24 Mar, 2039
(13 years from now)
| Active |
| US11000653 | Inhaler |
18 Dec, 2038
(12 years from now)
| Active |
| US11357935 | Drug delivery device with electronics |
24 Sep, 2038
(12 years from now)
| Active |
| US11351317
(Pediatric)
| Drug delivery device with electronics |
10 Aug, 2038
(12 years from now)
| Active |
| US11351317 | Drug delivery device with electronics |
10 Feb, 2038
(12 years from now)
| Active |
| US10569034
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
16 Feb, 2037
(11 years from now)
| Active |
| US10569034 | Compliance monitoring module for a breath-actuated inhaler |
16 Aug, 2036
(10 years from now)
| Active |
| US10918816
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
14 Jun, 2036
(10 years from now)
| Active |
| US9782550
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
28 Feb, 2036
(10 years from now)
| Active |
| US9782551
(Pediatric)
| Compliance monitoring module for a breath-actuated inhaler |
28 Feb, 2036
(10 years from now)
| Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler |
14 Dec, 2035
(9 years from now)
| Active |
| US9782550 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US8714149
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
25 Aug, 2032
(6 years from now)
| Active |
| US8978966
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jul, 2032
(6 years from now)
| Active |
| US10561808
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jul, 2032
(6 years from now)
| Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler |
25 Feb, 2032
(6 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Dec, 2031
(5 years from now)
| Active |
| US10022510
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
18 Nov, 2031
(5 years from now)
| Active |
| US10124131
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
18 Nov, 2031
(5 years from now)
| Active |
| US9731087
(Pediatric)
| Dose counter for inhaler having a bore and shaft arrangement |
18 Nov, 2031
(5 years from now)
| Active |
| US10195375
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
14 Aug, 2031
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler |
14 Feb, 2031
(5 years from now)
| Active |
| US8651103
(Pediatric)
| Dry powder inhalation apparatus |
26 Sep, 2028
(2 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US9463288
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9616024
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9616024 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US7540282
(Pediatric)
| Reservoir pressure system for medicament inhaler |
06 Nov, 2023
(2 years ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Armonair Digihaler's drug page
13. Armonair Respiclick
Armonair Respiclick is protected by 35 patents, out of which 14 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11969544
(Pediatric)
| Inhalers and airflow adaptors therefor |
20 Feb, 2040
(14 years from now)
| Active |
| US11969544 | Inhalers and airflow adaptors therefor |
20 Aug, 2039
(13 years from now)
| Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler |
14 Dec, 2035
(9 years from now)
| Active |
| US8714149
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
25 Aug, 2032
(6 years from now)
| Active |
| US8978966
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jul, 2032
(6 years from now)
| Active |
| US10561808
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jul, 2032
(6 years from now)
| Active |
| US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler |
25 Feb, 2032
(6 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Dec, 2031
(5 years from now)
| Active |
| US10022510
(Pediatric)
| Dose counters for inhalers, inhalers and methods of assembly thereof |
18 Nov, 2031
(5 years from now)
| Active |
| US10124131
(Pediatric)
| Dose counter for inhaler having an anti-reverse rotation actuator |
18 Nov, 2031
(5 years from now)
| Active |
| US9731087
(Pediatric)
| Dose counter for inhaler having a bore and shaft arrangement |
18 Nov, 2031
(5 years from now)
| Active |
| US10195375
(Pediatric)
| Airflow adaptor for a breath-actuated dry powder inhaler |
14 Aug, 2031
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler |
14 Feb, 2031
(5 years from now)
| Active |
| US8651103
(Pediatric)
| Dry powder inhalation apparatus |
26 Sep, 2028
(2 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US9463288
(Pediatric)
| Dry powder inhalation apparatus |
19 Nov, 2025
(a month ago)
| Expired |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9616024
(Pediatric)
| Process for preparing a medicament |
01 Mar, 2025
(10 months ago)
| Expired |
| US9616024 | Process for preparing a medicament |
01 Sep, 2024
(1 year, 4 months ago)
| Expired |
| US7540282
(Pediatric)
| Reservoir pressure system for medicament inhaler |
06 Nov, 2023
(2 years ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Armonair Respiclick's drug page
14. Austedo
Austedo is protected by 28 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11179386
(Pediatric)
| Analogs of deutetrabenazine, their preparation and use |
15 Sep, 2038
(12 years from now)
| Active |
| US11813232
(Pediatric)
| Analogs of deutetrabenazine, their preparation and use |
15 Sep, 2038
(12 years from now)
| Active |
| US11179386 | Analogs of deutetrabenazine, their preparation and use |
15 Mar, 2038
(12 years from now)
| Active |
| US11813232 | Analogs of deutetrabenazine, their preparation and use |
15 Mar, 2038
(12 years from now)
| Active |
| US10959996
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11357772
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11446291
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11564917
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11648244
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US12016858
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US10959996 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11357772 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11446291 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11564917 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11648244 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US12016858 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11666566
(Pediatric)
| Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US9233959
(Pediatric)
| Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US9296739
(Pediatric)
| Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US9550780
(Pediatric)
| Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US9814708
(Pediatric)
| Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US11666566 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US9233959 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US9296739 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US9550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US9814708 | Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US8524733
(Pediatric)
| Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
03 Oct, 2031
(5 years from now)
| Active |
| US8524733 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
03 Apr, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Austedo's drug page
15. Austedo Xr
Austedo Xr is protected by 21 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11311488 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof |
10 Jun, 2041
(15 years from now)
| Active |
| US11179386
(Pediatric)
| Analogs of deutetrabenazine, their preparation and use |
15 Sep, 2038
(12 years from now)
| Active |
| US11813232
(Pediatric)
| Analogs of deutetrabenazine, their preparation and use |
15 Sep, 2038
(12 years from now)
| Active |
| US11179386 | Analogs of deutetrabenazine, their preparation and use |
15 Mar, 2038
(12 years from now)
| Active |
| US11813232 | Analogs of deutetrabenazine, their preparation and use |
15 Mar, 2038
(12 years from now)
| Active |
| US10959996
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11357772
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11446291
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11564917
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US11648244
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US12016858
(Pediatric)
| Methods for the treatment of abnormal involuntary movement disorders |
07 Sep, 2036
(10 years from now)
| Active |
| US10959996 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11357772 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11446291 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11564917 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US11648244 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US12016858 | Methods for the treatment of abnormal involuntary movement disorders |
07 Mar, 2036
(10 years from now)
| Active |
| US9550780
(Pediatric)
| Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Mar, 2034
(8 years from now)
| Active |
| US9550780 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
18 Sep, 2033
(7 years from now)
| Active |
| US8524733
(Pediatric)
| Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
03 Oct, 2031
(5 years from now)
| Active |
| US8524733 | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
03 Apr, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Austedo Xr's drug page
16. Azilect
Azilect is protected by 5 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7815942 | Rasagiline formulations of improved content uniformity |
27 Aug, 2027
(1 year, 7 months from now)
| Active |
| US7572834 | Rasagiline formulations and processes for their preparation |
05 Dec, 2026
(10 months from now)
| Active |
| US5453446 | Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for treating Parkinson's disease. |
07 Feb, 2017
(8 years ago)
| Expired |
| US6126968 | Stable compositions containing N-propargyl-1-aminoindan |
18 Sep, 2016
(9 years ago)
| Expired |
| US5532415 | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
02 Jul, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azilect's drug page
17. Copaxone
Copaxone is protected by 13 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8232250 | Low frequency glatiramer acetate therapy |
19 Aug, 2030
(4 years from now)
| Active |
| US8399413 | Low frequency glatiramer acetate therapy |
19 Aug, 2030
(4 years from now)
| Active |
| US8969302 | Low frequency glatiramer acetate therapy |
19 Aug, 2030
(4 years from now)
| Active |
| US9155776 | Low frequency glatiramer acetate therapy |
19 Aug, 2030
(4 years from now)
| Active |
| US9402874 | Low frequency glatiramer acetate therapy |
19 Aug, 2030
(4 years from now)
| Active |
| US5981589 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US6054430 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US6342476 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US6362161 | Copolymer-1 improvements on compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US6620847 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US6939539 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US7199098 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
| US8367605 | Copolymer-1 improvements in compositions of copolymers |
24 May, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Copaxone's drug page
18. Loestrin 24 Fe
Loestrin 24 Fe is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5552394 | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
22 Jul, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loestrin 24 Fe's drug page
19. Loseasonique
Loseasonique is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7855190 | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
05 Dec, 2028
(2 years from now)
| Active |
| US7858605 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
23 Jun, 2023
(2 years ago)
| Expired |
| US7615545 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
15 Jun, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Loseasonique's drug page
20. Norethindrone And Ethinyl Estradiol And Ferrous Fumarate
Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6667050 | Chewable oral contraceptive |
06 Apr, 2019
(6 years ago)
| Expired |
| US5552394 | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
22 Jul, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norethindrone And Ethinyl Estradiol And Ferrous Fumarate's drug page
21. Prefest
Prefest is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7320970 | Low dose estrogen interrupted hormone replacement therapy |
30 Mar, 2020
(5 years ago)
| Expired |
| US6747019 | Low dose estrogen interrupted hormone replacement therapy |
20 Mar, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prefest's drug page
22. Preven Emergency Contraceptive Kit
Preven Emergency Contraceptive Kit is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6156742 | Emergency contraceptive kit |
05 Dec, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Preven Emergency Contraceptive Kit's drug page
23. Proair Digihaler
Proair Digihaler is protected by 27 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11266796 | Inhalation device with integrated electronics |
22 Feb, 2041
(15 years from now)
| Active |
| US11173259 | Drug delivery device with electronics and power management |
06 Jul, 2040
(14 years from now)
| Active |
| US11464923 | Inhaler system |
19 Jun, 2040
(14 years from now)
| Active |
| US11439777 | Drug delivery device with electronics |
24 May, 2040
(14 years from now)
| Active |
| US11344685 | Drug delivery device with electronics |
26 Sep, 2039
(13 years from now)
| Active |
| US11000653 | Inhaler |
18 Dec, 2038
(12 years from now)
| Active |
| US11357935 | Drug delivery device with electronics |
24 Sep, 2038
(12 years from now)
| Active |
| US11351317 | Drug delivery device with electronics |
10 Feb, 2038
(12 years from now)
| Active |
| US10569034 | Compliance monitoring module for a breath-actuated inhaler |
16 Aug, 2036
(10 years from now)
| Active |
| US10918816 | Compliance monitoring module for a breath-actuated inhaler |
14 Dec, 2035
(9 years from now)
| Active |
| US9782550 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Digihaler's drug page
24. Proair Hfa
Proair Hfa is protected by 14 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10086156 | Dose counter for inhaler and method for counting doses |
18 May, 2031
(5 years from now)
| Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US8132712 | Metered-dose inhaler |
07 Sep, 2028
(2 years from now)
| Active |
| US7105152 | Suspension aerosol formulations |
12 Sep, 2023
(2 years ago)
| Expired |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
| US7566445 | Medicinal aerosols and methods of delivery thereof |
04 Jun, 2017
(8 years ago)
| Expired |
| US8834849 | Medicinal aerosols and methods of delivery thereof |
04 Jun, 2017
(8 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Hfa's drug page
25. Proair Respiclick
Proair Respiclick is protected by 18 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9782550 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US9782551 | Compliance monitoring module for a breath-actuated inhaler |
28 Aug, 2035
(9 years from now)
| Active |
| US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof |
13 Jan, 2032
(5 years from now)
| Active |
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof |
28 Jun, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9731087 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US8651103 | Dry powder inhalation apparatus |
26 Mar, 2028
(2 years from now)
| Active |
| US10765820 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US9463288 | Dry powder inhalation apparatus |
19 May, 2025
(7 months ago)
| Expired |
| US7540282 | Reservoir pressure system for medicament inhaler |
06 May, 2023
(2 years ago)
| Expired |
| US6701917 | Dose counter for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6718972 | Dose metering system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US8006690 | Reservoir pressure system for medicament inhaler |
23 Jun, 2021
(4 years ago)
| Expired |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Proair Respiclick's drug page
26. Qnasl
Qnasl is protected by 5 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10188811 | Nasal spray device |
21 Oct, 2031
(5 years from now)
| Active |
| US7780038 | Dispensing apparatus with dosage counter |
24 Jan, 2027
(1 year, 7 days from now)
| Active |
| US5776432 | Beclomethasone solution aerosol formulations |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qnasl's drug page
27. Quartette
Quartette is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8415332 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
11 Mar, 2029
(3 years from now)
| Active |
| US8450299 | Methods of hormonal treatment utilizing ascending-dose extended cycle regimens |
07 Oct, 2025
(3 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Quartette's drug page
28. Qvar 40
Qvar 40 is protected by 12 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10086156 | Dose counter for inhaler and method for counting doses |
18 May, 2031
(5 years from now)
| Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
| US5776432 | Beclomethasone solution aerosol formulations |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qvar 40's drug page
29. Qvar 80
Qvar 80 is protected by 12 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator |
01 Jan, 2032
(5 years from now)
| Active |
| US10022509 | Dose counter for inhaler having a bore and shaft arrangement |
18 May, 2031
(5 years from now)
| Active |
| US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US10086156 | Dose counter for inhaler and method for counting doses |
18 May, 2031
(5 years from now)
| Active |
| US10695512 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US11395889 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US9463289 | Dose counters for inhalers, inhalers and methods of assembly thereof |
18 May, 2031
(5 years from now)
| Active |
| US9808587 | Dose counter for inhaler having an anti-reverse rotation actuator |
18 May, 2031
(5 years from now)
| Active |
| US6446627 | Inhaler dose counter |
18 Dec, 2017
(8 years ago)
| Expired |
| US5776432 | Beclomethasone solution aerosol formulations |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Qvar 80's drug page
30. Seasonale
Seasonale is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5898032 | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
23 Jun, 2017
(8 years ago)
| Expired |
| USRE39861 | Methods of extended use oral contraception |
23 Jun, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Seasonale's drug page
31. Seasonique
Seasonique is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7855190 | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
05 Dec, 2028
(2 years from now)
| Active |
| US7320969 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
30 Jan, 2024
(1 year, 11 months ago)
| Expired |
| US7858605 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
23 Jun, 2023
(2 years ago)
| Expired |
| US7615545 | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
15 Jun, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Seasonique's drug page
32. Synribo
Synribo is protected by 3 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6987103 | Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents |
26 Oct, 2026
(9 months from now)
| Active |
| US7842687 | Cephalotaxane derivatives and their processes of preparation and purification |
16 Mar, 2019
(6 years ago)
| Expired |
| USRE45128 | Cephalotaxane derivatives and their processes of preparation and purification |
16 Mar, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Synribo's drug page
33. Uzedy
Uzedy is protected by 12 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12329851 |
17 Mar, 2042
(16 years from now)
| Active | |
| US12128132 | Drug delivery formulations |
11 Sep, 2040
(14 years from now)
| Active |
| US12383493 |
11 Sep, 2040
(14 years from now)
| Active | |
| US9023897 | Biodegradable drug delivery compositions |
05 Apr, 2033
(7 years from now)
| Active |
| US8221778 | Drug-containing implants and methods of use thereof |
12 Nov, 2027
(1 year, 9 months from now)
| Active |
| US8741327 | Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant |
12 Nov, 2027
(1 year, 9 months from now)
| Active |
| US10736965 | Risperidone biodegradable implant |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
| US8802127 | Risperidone-containing PLA:PGA implants and methods of use thereof |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
| US9439905 | Risperidone-containing implants and methods of use thereof |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
| US9717799 | Drug-containing implants and methods of use thereof |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
| US9895447 | Drug-containing PLA implants and methods of use thereof |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
| US9925268 | Drug-containing implants and methods of use thereof |
12 Jan, 2025
(1 year, 4 days ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Uzedy's drug page
34. Vandazole
Vandazole is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7456207 | Vaginal pharmaceutical compositions and methods for preparing them |
22 Sep, 2024
(1 year, 3 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vandazole's drug page
35. Vantrela Er
Vantrela Er is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8445018 | Abuse resistant drug formulation |
31 Jul, 2029
(3 years from now)
| Active |
| US9216176 | Abuse resistant drug formulation |
13 Sep, 2027
(1 year, 7 months from now)
| Active |
| US9572803 | Abuse resistant drug formulation |
13 Sep, 2027
(1 year, 7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vantrela Er's drug page
36. Zecuity
Zecuity is protected by 10 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9327114 | User-activated self-contained co-packaged iontophoretic drug delivery system |
08 Oct, 2032
(6 years from now)
| Active |
| US8983594 | Electronic control of drug delivery system |
19 Nov, 2030
(4 years from now)
| Active |
| US8366600 | Polyamine enhanced formulations for triptan compound iontophoresis |
21 Apr, 2029
(3 years from now)
| Active |
| US9272137 | Transdermal methods and systems for the delivery of anti-migraine compounds |
07 Sep, 2027
(1 year, 7 months from now)
| Active |
| US7973058 | Transdermal methods and systems for the delivery of anti-migraine compounds |
12 Apr, 2027
(1 year, 2 months from now)
| Active |
| US8155737 | Pharmacokinetics of iontophoretic sumatriptan administration |
12 Apr, 2027
(1 year, 2 months from now)
| Active |
| US8470853 | Transdermal methods and systems for the delivery of anti-migraine compounds |
12 Apr, 2027
(1 year, 2 months from now)
| Active |
| US8597272 | Pharmacokinetics of iontophoretic sumatriptan administration |
12 Apr, 2027
(1 year, 2 months from now)
| Active |
| US9427578 | Pharmacokinetics of iontophoretic sumatriptan administration |
12 Apr, 2027
(1 year, 2 months from now)
| Active |
| US6745071 | Iontophoretic drug delivery system |
21 Feb, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zecuity's drug page